Daf Yomi · Startup Mensch · Standard

Chullin 38

StandardStartup MenschJune 7, 2026

Hook

Every founder faces the "Convulsion Dilemma"—the moment your startup is technically "dead" (the market has shifted, the funding has dried up, the product-market fit has evaporated), yet you see a twitch, a sound, or a slight movement in your metrics that keeps you in the game. You are staring at the carcass of your original vision, asking: "Is this a sign of life, or is it just the dying spasms of a business that should have been buried months ago?"

In Chullin 38, the Sages debate the precise physiological markers that distinguish a living creature from a corpse during the slaughter. They are not arguing over theology; they are arguing over the integrity of reality. If the movement is a natural reaction to the cessation of life, it’s a "convulsion" (a death spasm). If the movement is a proactive, intentional response, it’s a "sign of life."

As a founder, you are the slaughterer. You are constantly "killing" sub-optimal features, stagnant product lines, and failing GTM strategies. The danger isn't that you’ll kill them too soon—it’s that you’ll mistake the "convulsions" of a dying strategy for the "signs of life" of a new one. You see a spike in user engagement because of a massive discount, and you call it "traction." You see an employee grinding away, and you call it "culture" even if they are just reacting to the stress of your own poor management. The Gemara asks us to be cold-blooded analysts: Is this movement engendered by death (the status quo failing), or is it engendered by life (the business model actually scaling)? If you cannot tell the difference, you aren't leading—you’re just watching a corpse twitch.

Analysis

Insight 1: The "Death-Engendered" Fallacy (Truth)

The Gemara provides a ruthless diagnostic tool: "Any movements of the animal that are not matters that the death of the animal engenders are convulsions sufficient to render the slaughter valid" Chullin 38a.

In your business, death-engendered movements are the results of your business’s inevitable collapse, not its growth. If your churn rate drops only because you stopped billing the customers, that is not a "sign of life"; it is a death spasm. If your sales numbers are up because you are selling at a loss, that is not growth; it is the final twitch of a failing unit economic model. You must learn to discount any metric that is merely a byproduct of your own desperation. A "rich and powerful voice" (a loud marketing campaign) is only a sign of life if it is backed by the force of product-market fit. If the voice is "muted," no amount of amplification will make it a living thing.

Insight 2: Contextualizing the Metric (Fairness)

"The convulsion that the Sages said is an indication of life is a convulsion at the conclusion of the act of slaughter" Chullin 38a. There is a temporal dimension to success. Many founders judge their startup's health at the beginning of a process—right when they launch a feature or pivot. But the Gemara warns that early, reactionary movements are often just the system adjusting to the shock of the change.

Real signals appear at the conclusion of the slaughter—when the dust has settled, the initial hype is gone, and the operational reality hits. If you are measuring "signs of life" based on your PR launch week or your first month of burn, you are making a rookie mistake. Real viability is tested after the "slaughter" of the old ways of doing things. Can the business stand on its own once the initial "force" of your founder-driven energy is removed? If the business only moves when you are manually pushing the foreleg, it is dead.

Insight 3: The Hierarchy of Evidence (Competition)

The Gemara debates whether "spurting blood" is a better sign of life than "wiggling an ear" Chullin 38a. They conclude that some indicators are "superior" to others.

In business, we often treat all KPIs as equal. This is a fatal error. You must establish a hierarchy of evidence. A customer who provides a referral is a "superior" sign of life compared to a customer who clicks an ad. A customer who pays a premium price is "superior" to one who uses a free trial. When you are in a competitive market, you cannot afford to be fooled by "less substantive" indications of life. If your competitor is growing through high-LTV (Life-Time Value) users and you are growing through "wiggling ears" (vanity metrics like daily page views), you are losing, even if your growth charts look similar on the surface. Stop optimizing for the "wiggle" and start building for the "spurt."

Policy Move

The "Autopsy Review" Process

To prevent the delusion of the "twitching corpse," implement a monthly "Autopsy Review" for every major project or product line.

  1. The Threshold: Any feature or initiative that has not hit its primary KPI for two consecutive cycles (sprints or months) is officially marked for "slaughter."
  2. The Test: For the next 30 days, you remove all artificial life support—no additional marketing spend, no cross-subsidization from other products, no "founder intervention."
  3. The Observation: At the end of the 30 days, the team must present evidence of "life" that was not "engendered by the death" of the project. If the only engagement is coming from legacy users or is a direct result of the sunsetting process (e.g., users trying to export data before you kill the product), it is a convulsion.
  4. The Decision: If the evidence is a convulsion, the project is killed permanently. No second chances.

KPI Proxy: "Organic Retention Rate after Subsidy Removal" (ORR-ASR). This measures how many users stay when you stop paying to keep them there. If this number is < 5%, you are watching a corpse twitch.

Board-Level Question

"We are currently tracking [X] metric as our primary indicator of market traction. If we were to remove the 'life support' of [current marketing spend/discounting/founder manual labor], would this metric hold, or is this simply a reaction to the change we've forced upon the system? Are we observing a living organism, or are we confusing a convulsion for growth?"

Takeaway

Stop measuring your startup by its spasms. A twitch is not a trend. A reaction is not a strategy. If you aren't willing to stop the "slaughter" of your bad ideas, you will never be able to distinguish the living ones from the dead. Your job is not to keep the business moving at all costs; your job is to ensure that the things that are moving are actually alive. Be the founder who knows when to bury the dead, so the living can finally breathe.